1. Home
  2. BEAT vs ABLV Comparison

BEAT vs ABLV Comparison

Compare BEAT & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAT
  • ABLV
  • Stock Information
  • Founded
  • BEAT 2015
  • ABLV 2015
  • Country
  • BEAT United States
  • ABLV China
  • Employees
  • BEAT N/A
  • ABLV N/A
  • Industry
  • BEAT Retail: Computer Software & Peripheral Equipment
  • ABLV
  • Sector
  • BEAT Technology
  • ABLV
  • Exchange
  • BEAT Nasdaq
  • ABLV Nasdaq
  • Market Cap
  • BEAT 57.6M
  • ABLV 51.4M
  • IPO Year
  • BEAT 2021
  • ABLV N/A
  • Fundamental
  • Price
  • BEAT $1.63
  • ABLV $0.98
  • Analyst Decision
  • BEAT Buy
  • ABLV
  • Analyst Count
  • BEAT 1
  • ABLV 0
  • Target Price
  • BEAT $8.00
  • ABLV N/A
  • AVG Volume (30 Days)
  • BEAT 73.9K
  • ABLV 21.0K
  • Earning Date
  • BEAT 11-07-2025
  • ABLV 01-01-0001
  • Dividend Yield
  • BEAT N/A
  • ABLV N/A
  • EPS Growth
  • BEAT N/A
  • ABLV N/A
  • EPS
  • BEAT N/A
  • ABLV 0.05
  • Revenue
  • BEAT N/A
  • ABLV $114,319,869.00
  • Revenue This Year
  • BEAT N/A
  • ABLV N/A
  • Revenue Next Year
  • BEAT $19.35
  • ABLV N/A
  • P/E Ratio
  • BEAT N/A
  • ABLV $19.49
  • Revenue Growth
  • BEAT N/A
  • ABLV N/A
  • 52 Week Low
  • BEAT $0.91
  • ABLV $0.55
  • 52 Week High
  • BEAT $3.48
  • ABLV $1.77
  • Technical
  • Relative Strength Index (RSI)
  • BEAT 49.06
  • ABLV 51.82
  • Support Level
  • BEAT $1.53
  • ABLV $0.88
  • Resistance Level
  • BEAT $1.81
  • ABLV $1.12
  • Average True Range (ATR)
  • BEAT 0.12
  • ABLV 0.08
  • MACD
  • BEAT -0.03
  • ABLV -0.00
  • Stochastic Oscillator
  • BEAT 25.00
  • ABLV 39.88

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

Share on Social Networks: